STOCK TITAN
  1. Home
  2. News
  3. MEDS

Trxade Health Inc - MEDS STOCK NEWS

Welcome to our dedicated news page for Trxade Health (Ticker: MEDS), a resource for investors and traders seeking the latest updates and insights on Trxade Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trxade Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trxade Health's position in the market.

News
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
Rhea-AI Summary
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Files for Extension to Submit Q2 Quarterly Report, Citing Merger Transaction as Reason. Financial Results to be Released on August 18, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.8%
Tags
none
-
News
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.55%
Tags
management acquisition
-
News
TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time
Rhea-AI Summary
TRxADE HEALTH INC. (NASDAQ:MEDS) will release financial results for Q2 2023 on August 14, 2023. A conference call will be held to discuss the results. Webcast and playback options are available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.57%
Tags
conferences earnings
News
TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
acquisition
-
News
TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.
Rhea-AI Summary
TRxADE HEALTH, Inc. (NASDAQ: MEDS) has entered into an amended and restated merger agreement with Superlatus, Inc. Shareholders of Superlatus will receive an aggregate of 30,821,941 shares of MEDS stock at $7.30 per share. Additionally, TRxADE will issue MEDS Rights to its shareholders, allowing them to receive one share of MEDS common stock at no cost for every seven shares of TRxADE common stock held.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
Superlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and Distribution
Rhea-AI Summary
Superlatus, Inc. has signed a definitive agreement to be acquired by TRxADE HEALTH, Inc. Shareholders of Superlatus will receive 173,463 shares of MEDS stock. MEDS plans to divest its existing operating business and assets. The Merger is subject to closing conditions including completion of due diligence and regulatory approvals. The combined company will focus on creating an innovative global consolidation platform for the food and healthy snack industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
acquisition
News
TRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
EAT WELL GROUP TO SELL SAPIENTIA FOR USD $10 MILLION IN NASDAQ MERGER WITH MEDS & SUPERLATUS FOODS
Rhea-AI Summary
Eat Well Investment Group Inc. has entered into a membership interest purchase agreement to sell its subsidiary Sapientia Technology Inc. to Superlatus, Inc. as part of a NASDAQ merger with TRxADE HEALTH, Inc. The sale of Sapientia allows Eat Well Group to focus on its agricultural strategy and pursue M&A opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
acquisition
-
News
Superlatus, Inc. to Combine with TRxADE HEALTH, Inc., to Create a Global Food Consolidation Platform
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.62%
Tags
none
News
TRxADE Health, Inc.’s Board of Directors Approves Reverse Stock Split
Rhea-AI Summary
TRxADE Health, Inc. (Nasdaq: MEDS) has approved a 1-for-15 reverse stock split of its common stock. The split will reduce outstanding shares from 10,210,878 to 680,726, resulting in an expected increase in the bid price of the stock. The reverse stock split aims to increase marketability to potential investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.51%
Tags
management
Stock MEDS logo
Trxade Health Inc

Nasdaq:MEDS

MEDS Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

MEDS Stock Data

8.81M
452.08k
28.08%
5.66%
2.82%
Wholesale Trade Agents and Brokers
Wholesale Trade
Link
US
Lutz

About MEDS

trxade.com is quickly becoming the nation's largest web-based pharmaceutical purchasing and analytics system. our revolutionary supplier e-stores allow buyers to shop and compare products and pricing of pharmaceutical suppliers nationwide. this forward thinking platform creates supplier competition and drives down cost for the buyers like never before. our secure system also allows buyers to track all of their purchases in one, easy to manage location with analytical tools available to make more educated and informed purchasing decisions. trxade.com membership is offered only to licensed pharmaceutical buyers (pharmacies, long term care facilities, hospitals, physicians, etc.). our safe and secure system allows buyers to search for products, compare pricing and submit immediate purchase orders to some of the nation's most well known and respected suppliers.